An estimated 18,000 people in the United States annually suffer from new injuries to their spinal cords. Unfortunately for ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer ...

The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on genetic mutations.

The U.S. Food and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the treatment of adult ...

Inhibikase Therapeutics, Inc.’s IKT share price has dipped by 5.30%, which has investors questioning if this is right time to buy.

U.S. FDA Grants Full Approval of VITRAKVI® (larotrectinib) for Adult and Pediatric Patients with NTRK Gene Fusion-Positive ...

Priovant Therapeutics’ PF-06700841-15 (brepocitinib tosylate), a non receptor tyrosine protein kinase TYK2 inhibitor and ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...